IL6 and COVID-19: A meta‐analysis of IL‐6 concentrations in hospital patients with COVID‐19 revealed levels approximately three times higher in patients with more severe COVID‐19 complications, compared with patients suffering from other, “non‐complicated,” diseases (Coomes & Haghbayan, 2020).